Anti-Seizure Medications Withdrawals After 2 Years of Seizure Remission
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,200
- 试验地点
- 1
- 主要终点
- Patients umber of seizure recurrence
研究概览
简要总结
The proper period of anti-seizure medication (ASM) treamtment is important for decreasing side effect of ASM and recurrence of seizure. We evaluate reliable risk factor analysis for safe withdrawal of ASM in children with epilepsy. Futhermore, we develop the scoring system for prediction of seizure recurrence to set the standard for safe withdrawal of ASM.
详细描述
The proper period of anti-seizure medication (ASM) treamtment is important for decreasing side effect of ASM and recurrence of seizure. We evaluate reliable risk factor analysis for safe withdrawal of ASM in children with epilepsy. Futhermore, we develop the scoring system for prediction of seizure recurrence to set the standard for safe withdrawal of ASM.
The enroll criteria as follow:
- patients with epilepsy or acute provoked seizure accroding to the ILAE definition
- patients who have been 2 years of seizure free with or without ASM
The patients with seizure recurrence during follow-up or end of follow-up period of 24 months will end this stutdy.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- — 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with Epilepsy or acute provoked seizure according to the ILAE guideline
- •Patients with 2 years of seizure free periods
排除标准
- •Uncertain diagnosis of epilepsy or acute provoked seizure
- •Patients who do not want to participate in the study
结局指标
主要结局
Patients umber of seizure recurrence
时间窗: Up to 2 years
Patients umber of seizure recurrence
次要结局
未报告次要终点
研究者
Min-Sun Yum
Professor
Asan Medical Center